International Journal of Food Sciences and Nutrition · 2019 · 49 citations · 27 references
MedicinePharmacologyPharmacotherapyCardiovascular PharmacotherapyClinical NutritionClinical PharmacologyCardiovascular DiseaseDiabetes MellitusDiabetes PharmacotherapyInsulin ResistanceLipid-lowering TherapyMedicinal PlantsAdvanced Glycation End ProductsArterial StiffnessDouble-blind TrialsLipid Profile ChangesStiffnessTea PolyphenolsTissue StiffeningVascular Stiffness
Type 2 diabetes mellitus (T2DM) is associated with premature atherosclerosis and arterial stiffening due to the accumulation of advanced glycation end-products in vessel walls. Green tea polyphenols are considered cardio-protective substances. In this randomised double-blind placebo-controlled trial (NCT02627898), we evaluated the effect of Green tea extract on arterial stiffness parameters, lipids, body composition and sRAGE levels. Twenty normotensive patients with T2DM treated with the standard therapy and statins, mean age 53.2 ± 9.4 years and mean BMI 30.1 ± 4.5 kg/m2, were randomised to receive a daily dose of 400 mg of green tea extract (polyphenols ≥90%, EGCG ≥45%) or placebo for 12 weeks. Compared to placebo, administration of green tea extract decreased central augmentation index (–3.05 ± 10.8% vs. 6.7 ± 0.1%, p = .04). These findings suggest that green tea extract could be used as an adjunct to the standard therapy to improve arterial stiffness in T2DM.
27
Joep Perk, Guy De Backer, H. Gohlke et al. · European Heart Journal · 2012 · 8.5K citations · Full text
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Massimo Piepoli, Arno W. Hoes, Stefan Agewall et al. · Atherosclerosis · 2016 · 488 citations · Full text